Author: neuroadmin

Dr. Cyrus Zabetian has received over $1.2 million in funding for his study:

Genetic Movement Disorders: Etiologies and Pathogeneses
The major goal of this project is to identify the molecular etiologies of genetic movement disorders as an important step towards improving diagnoses, elucidating pathogeneses, and facilitating efforts to develop targeted therapies.

VA BLR&D Program Officials can nominate one fundable grant from their panels each cycle. Dr. Chris Ransom was nominated and received the Award for his research:

“Regulation of extrasynaptic GABA-A receptors in health and disease”

This project will study cellular and molecular changes that occur after experiment TBI, with focus on extrasynaptic GABA receptors (both GABA-A and GABA-B receptors) in areas of the brain that are not directly involved in cortical impact (i.e. hippocampus and thalamus). It will also assess the microglia-dependence of TBI-related cellular/molecular changes and functional outcomes (e.g. epileptic seizures) using approaches to deplete microglia or limit microglia responses to injury.

Knowing the signs and symptoms of stroke and acting FAST is crucial when it comes to stroke care. Our EMS partners are the first responders to the community play an key part in this care. UW Medicine Stroke Team members Dr. David Tirschwell, Kelsey Hagstrand, ARNP and Kelly Bender Outreach Liaison met with Seattle Fire Station 28 EMS teams to build on that prehospital to hospital optimal stroke care partnership. UW Medicine provides emergency stroke care at Harborview Medical Center and the University of Washington Medical Centers.

The UW Regional Epilepsy Center has been re-credentialed by the National Association of Epilepsy Centers as a NAEC Level 4 Center for 2022 and 2023. This is their highest-level designation and certifies that our Center is capable of handling the most complicated surgical epilepsy cases.